Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ALKS 4230
ALKS 4230
Esmo 2020 – can Alkermes succeed where Nektar failed?
EP Vantage
Wed, 09/23/20 - 10:33 am
Alkermes
ESMO
ALKS 4230
melanoma
ESMO: Alkermes' major I-O hope sees progress across early cancer tests
Fierce Biotech
Fri, 09/18/20 - 11:09 am
Alkermes
immuno-oncology
ESMO
ALKS 4230
Keytruda